💊
Therapeutic advances
Introduced and supported modern medication pathways, including Perfalgan, Jadenu, Ferriprox, recombinant factor VIII and IX products, and Hemlibra, according to approved indications and institutional protocols.
🩸 Senior pediatric hematology leadership
About the Senior Consultant Pediatric Hematologist.
A senior consultant pediatric hematologist with more than 25 years of clinical, academic, and program-development experience, dedicated to advancing comprehensive care for children with sickle cell disease, thalassemia, hemophilia, and complex pediatric blood disorders.
25+years of experience
3comprehensive programs established
7international conference editions chaired
QOLpatient quality-of-life focus
Professional profile
A career focused on building modern pediatric hematology care.
With over two and a half decades of experience, the senior consultant has contributed to the development of structured, multidisciplinary pediatric hematology services, with particular emphasis on inherited red-cell disorders and bleeding disorders.
Core mission: to improve survival, safety, access to modern therapies, complication screening, and quality of life for children and families affected by sickle cell disease, thalassemia, hemophilia, and related blood disorders.
Comprehensive programs established
- Established a comprehensive pediatric sickle cell disease program with structured preventive care, vaccination strategies, complication screening, and family education.
- Established a comprehensive pediatric thalassemia program integrating transfusion support, iron overload surveillance, chelation therapy pathways, and long-term monitoring.
- Established a comprehensive pediatric hemophilia program focused on factor replacement, inhibitor screening, modern prophylaxis, emergency planning, and joint-health protection.
Clinical innovation
Introduced modern therapies, screening tools, and diagnostic pathways.
These contributions helped strengthen pediatric hematology services by bringing contemporary medications, surveillance tools, and specialized testing into routine care pathways.
🛡️
Sickle cell prevention
Introduced updated vaccination strategies and preventive-care pathways for children with sickle cell disease, supporting infection prevention and safer long-term care.
🧠
Stroke-risk screening
Introduced transcranial Doppler ultrasound screening for children with sickle cell disease to help identify increased stroke risk and guide preventive intervention.
🧲
Iron overload monitoring
Introduced cardiac and liver T2* MRI assessment to improve monitoring of iron overload in transfusion-dependent patients, especially children with thalassemia and other chronically transfused disorders.
🧪
Hemophilia inhibitor testing
Introduced inhibitor testing in hemophilia care to improve early detection of factor inhibitors and support safer, more individualized treatment planning.
🌟
Quality-of-life impact
Improved quality of life for children and families affected by sickle cell disease, thalassemia, and hemophilia through multidisciplinary care, prevention, education, and access to modern therapies.
Academic leadership
Chair of the International Pediatric Hematology Conference.
Served as Chair of the International Pediatric Hematology Conference for editions 1 through 7, helping build a platform for clinical education, scientific exchange, regional collaboration, and advancement of pediatric hematology practice.
Areas of major contribution
- Sickle cell disease comprehensive care and complication prevention.
- Thalassemia transfusion, chelation, and iron overload monitoring.
- Hemophilia treatment modernization, recombinant factors, Hemlibra, and inhibitor testing.
- Pediatric hematology education, conference leadership, and multidisciplinary program development.
Patient-centered care
Advancing pediatric hematology through prevention, innovation, and education.
The program philosophy emphasizes early diagnosis, structured screening, modern therapy, family education, and long-term quality-of-life improvement.